Sign in

NCT06889532Recruiting

SAVE Studie- SArcoma Surgery With Vacuum Enhanced Wound Treatment Randomised Study to Evaluate the Wound Management in Sarcoma Surgery

SAVE Studie- SArcoma Surgery With Vacuum Enhanced Wound Treatment Randomised Controlled Study to Evaluate the Wound Management in Sarcoma Surgery

Source: ClinicalTrials.gov · Last updated 21 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The aim of this study is to evaluate local complications following sarcoma resection in the groin and thigh regions with regard to the planned wound closure method. To this end, temporary soft tissue coverage using a vacuum-assisted closure (VAC) system and delayed secondary closure with wound sutures and drainage placement will be compared to primary closure with drainage in terms of wound infections, revisions, and seroma formation.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
23 Feb 2025
Start date
1 Nov 2024
Primary completion date
31 Dec 2025
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Diseases
Sarcoma
NCT number
NCT06889532

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 1 Nov 2024 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with local recurrences or prior wound healing complications in the surgical area.
  • for whom direct closure is not possible during the initial surgery due to the extent of resection.

Other illness

  • Patients with ulcerating or infected tumors, or those requiring emergency surgery.

Other

  • Tumors smaller than 5 cm and superficial masses.
  • Other Soft Tissue Tumors such as Kaposi sarcoma.

Who the study is looking for

  • Patients must be over 18 years old.
  • Patients of any gender and background can be included.
  • The largest tumor diameter on imaging must be at least 5 cm. Preoperative imaging is required to assess tumor dimensions.
  • Sarcomas must be located in the lower extremity or groin.
  • Cases must be discussed preoperatively at an interdisciplinary tumor board.
  • Patients must provide informed consent to participate in the study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Universitätsklinikum Hamburg-Eppendorf
Coordinator of this site? Confirm its status
HamburgGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.